•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Insider Sees Opportunity, Buys 10,000 Shares of REIT Valued at Nearly $725,000
Rates Up, REITs Down! Exploring The Ten Year Treasury's Relationship With Net Lease REITs
5 Monthly Dividend Payers Boomers Have Quietly Made Core Holdings
5 Monthly Dividend Stocks Built to Keep the Checks Coming
Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
The Ultimate SWAN Investment: Why Retirees Should Own Net Lease REITs
Agree Realty Director Rakolta Buys 20,136 Shares for $1.5 Million
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
3 Landlord Stocks That Collect the Rent and Pay You the Dividends
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
These 2 REIT Dividends Look Equally Safe—Until You Dig Into the Numbers
The Monthly-Payer Portfolio: How a 67-Year-Old Collects $3,700 Every Month From O, ADC, and GBDC
How an 80-Year-Old Collects $7,100 a Month Without Selling a Single Share
Lock In Monthly Income: 5 September Strong Buys With High Yields
Comparing Mercialys (OTCMKTS:MEIYF) & Agree Realty (NYSE:ADC)
Why I Am A Dividend Growth Investor (At Age 35)
Realty Income: Business Expansion Has Not Accelerated Growth
5 Monthly Pay REITs for Dependable Retirement Cash Flow
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology